摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-(2-amino-4-oxazolyl)-2-methoxyimino-acetate | 86312-71-2

中文名称
——
中文别名
——
英文名称
ethyl 2-(2-amino-4-oxazolyl)-2-methoxyimino-acetate
英文别名
ethyl 2-[2-aminooxazol-4-yl]-2-Z-methoximinoacetate;ethyl 2-(2-aminooxazol-4-yl)-2-methoxyiminoacetate;ethyl (2Z)-2-(2-amino-1,3-oxazol-4-yl)-2-methoxyiminoacetate
ethyl 2-(2-amino-4-oxazolyl)-2-methoxyimino-acetate化学式
CAS
86312-71-2
化学式
C8H11N3O4
mdl
——
分子量
213.193
InChiKey
BARYHMCDDRYGMN-WDZFZDKYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    148-149 °C(Solv: isopropyl ether (108-20-3))
  • 沸点:
    340.9±52.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    99.9
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Oxazole and oxadiazole cephalosporins
    申请人:Eli Lilly and Company
    公开号:US04406898A1
    公开(公告)日:1983-09-27
    Broad spectrum cephalosporin antibiotics represented by the betaine structure of the formula ##STR1## wherein R is a 5-membered amino-substituted heterocyclic containing oxygen and nitrogen; R' is e.g., hydrogen or C.sub.1 -C.sub.4 alkyl; and bicyclicpyridinium is a thienopyridinium or a furopyridinium group; are prepared by reacting a silylated 3-iodomethyl cephalosporin with a thienopyridine, e.g., thieno[2,3-b]pyridine or a furopyridine. The compounds are potent antibacterials against gram-positive and gram-negative organisms. Pharmaceutical compositions and a method for treating bacterial infections are also provided.
    广谱头孢菌素抗生素,以公式##STR1##中的甜菜碱结构代表,其中R是含氧和氮的5-成员基取代杂环;R'是例如,氢或C.sub.1 -C.sub.4烷基;并且双环吡啶是一种噻吡啉或呋吡啉基团;通过将硅烷化的3-甲基头孢菌素与噻吡啉(例如,噻[2,3-b]吡啶或呋吡啉)反应制备。这些化合物对革兰氏阳性和阴性细菌有很强的抗菌作用。还提供了用于治疗细菌感染的药物组合物和方法。
  • Oximino-substituted cephalosporin compounds
    申请人:Eli Lilly and Company
    公开号:US04379787A1
    公开(公告)日:1983-04-12
    Broad spectrum cephalosporin antibiotics represented by the formula ##STR1## wherein R is an amino-substituted oxazole, oxadiazol, or isoxazole heterocyclic, R' is C.sub.1 -C.sub.4 alkyl, a carboxysubstituted alkyl or cycloalkyl group, etc., and .sup..sym. R.sub.1 is an oximino-substituted pyridinium, quinolinium or isoquinolinium group, e.g., .sup..sym. R.sub.1 is a 3- or 4-formylpyridinium oxime group; pharmaceutical compositions comprising the antibiotic, and a method for treating antibacterial infections are provided.
    广谱头孢菌素抗生素的化学式为##STR1##,其中R是基取代的噁唑噻二唑异噁唑杂环,R'是C.sub.1 -C.sub.4烷基、羧基取代的烷基或环烷基等,.sup..sym. R.sub.1是氧亚胺取代的吡啶喹啉异喹啉基团,例如,.sup..sym. R.sub.1是3-或4-甲醛吡啶基团;提供了包含该抗生素的药物组合物,以及治疗抗菌感染的方法。
  • 3'-Substituted quinolinium cephalosporins
    申请人:Eli Lilly and Company
    公开号:US04382931A1
    公开(公告)日:1983-05-10
    Broad spectrum cephalosporin antibiotics represented by the formula ##STR1## are provided. In the formula, R represents a 2-aminooxazol-4-yl, 5-amino-1,2,4-oxadiazol-3-yl, or 5-aminoisoxazol-3-yl heterocyclic group; R' is hydrogen, C.sub.1 -C.sub.4 alkyl, a carboxy-substituted alkyl or cycloalkyl group or a C.sub.1 -C.sub.4 alkyl ester or carboxy-protecting ester derivative thereof; or an N-substituted carbamoyl group; and R.sub.1 and R.sub.2 are independently hydrogen or a substituent group, eg. halo, hydroxy, amino, carbamoyl, alkyl, or trifluoromethyl. The antibiotics are useful in a method for treating bacterial infections and can be formulated into pharmaceutical formulations for such use.
    提供了以##STR1##表示的广谱头孢菌素抗生素。在公式中,R代表2-噁唑-4-基,5-基-1,2,4-噁二唑-3-基,或5-异噁唑-3-基杂环基团;R'是氢,C.sub.1 -C.sub.4烷基,羧基取代的烷基或环烷基团,或C.sub.1 -C.sub.4烷基酯或羧基保护酯衍生物;或N-取代的基甲酰基团;而R.sub.1和R.sub.2独立地是氢或取代基团,例如,卤素,羟基,基,基甲酰基,烷基,或三甲基。这些抗生素可用于治疗细菌感染的方法,并可制成用于此类用途的药物制剂。
  • 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
    申请人:Eli Lilly and Company
    公开号:US04430499A1
    公开(公告)日:1984-02-07
    Cephalosporin broad spectrum antibiotics possessing a 7.beta.-[2-[(2-aminooxazol)-4-yl]-2-(substituted oximino)acetamido side chain and a variety of substituents at the 3-position of the cephalosporins are claimed. Also claimed are intermediates in the synthesis of the above cephalosporin antibiotics.
    声明了具有7.beta.-[2-[(2-噁唑)-4-基]-2-(取代氧基)乙酰胺侧链和在头孢菌素的3-位置具有多种取代基的头孢菌素广谱抗生素。此外,还声明了上述头孢菌素抗生素的合成中间体。
  • WHEELER, W. J.
    作者:WHEELER, W. J.
    DOI:——
    日期:——
查看更多